Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species is a research paper published in PLoS Pathogens (2022). On theSindex it has a DataRank of 0.655. It has been cited 16 times, with 13 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0.230
From 12 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 13 citers.
National Institutes of Health
Grant: AI154559
National Institutes of Health
Grant: AI129703
National Institutes of Health
Grant: AI147723
National Institutes of Health
Grant: P51 OD011092
National Institutes of Health
Grant: 3P51OD011092-55S1
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
National Institutes of Health
Grant: 5R01AI154559-02
A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission
National Institutes of Health
Grant: 2R01AI129703-06A1
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
National Institutes of Health
Grant: 5R21AI147723-02
A CCR5 Blocking Antibody as HIV Pre-exposure Prophylaxis
Fields of Study
Keywords
Sustainable Development Goals